Big Pharma Earnings Watch: Eli Lilly

Brand Name Giant ‘Smashes’ Wall Street Expectations After Price Hikes on Diabetes, Cancer Medications

New first quarter earnings reports released today from brand name giant Eli Lilly prove once again that repeated price hikes continue to support big time profits for Big Pharma. Eli Lilly bested Wall Street expectations after hiking prices on blockbuster on a diabetes treatment.

The strong earnings reports come after Eli Lilly repeatedly hiked prices on their prescription drugs.

Stay tuned as we continue to monitor Q1 earnings announcements from brand name drug makers over the coming weeks. Check out the key takeaways from Q1 earnings calls from Johnson & Johnson and Roche HERE and HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.